A Montgomery County resident is facing charges for insider trading, tied to CVS's acquisition of Oak Street Health last year. Carlos Sacanell, the man in question, made a considerable sum of around $617,000 by trading on nonpublic information, as announced by U.S. Attorney Jacqueline C. Romero.
According to the U.S. Attorney's Office for the Eastern District of Pennsylvania, the 58-year-old Sacanell got his insider information from a domestic partner, an executive at Oak Street Health. He then allegedly used this knowledge not yet known to the public to trade Oak Street Health stocks and options in advance of the deal's announcement, leading to his substantial profits.
An indictment was brought against Sacanell, which in addition to the insider trading charges, included making false statements to a federal agency. On April 3, 2024, when interviewed by the FBI, Sacanell lied, claiming he had no advance knowledge of the CVS's plans to acquire Oak Street Health. This, despite it being a critical piece of his allegedly illicit trading strategy.
The implications for Sacanell are severe, with a potential sentence of up to 25 years in prison if convicted. The case, now in the hands of Assistant United States Attorney Francis A. Weber, is bolstered by an investigation spearheaded by the FBI. Meanwhile, the Securities and Exchange Commission has also unveiled charges against Sacanell in a related civil matter.
As this is a matter of an ongoing legal process, it's important to note that an indictment is an accusation, not proof. Carlos Sacanell, like any defendant, remains presumed innocent until proven guilty in a court of law. Further details on the case and its development will be closely observed as they unfold.
